PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 23 filers reported holding PHARVARIS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,472,000 | -67.8% | 1,104,552 | -7.2% | 0.17% | -68.9% |
| Q2 2022 | $26,307,000 | -8.0% | 1,190,343 | -24.5% | 0.54% | -15.0% |
| Q1 2022 | $28,600,000 | +25.7% | 1,577,078 | -0.3% | 0.64% | +34.0% |
| Q4 2021 | $22,755,000 | -20.2% | 1,581,331 | -1.7% | 0.48% | -14.4% |
| Q3 2021 | $28,518,000 | +48.2% | 1,608,471 | +55.7% | 0.56% | +62.9% |
| Q2 2021 | $19,240,000 | -33.4% | 1,032,757 | 0.0% | 0.34% | -43.7% |
| Q1 2021 | $28,897,000 | – | 1,032,757 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,743,450 | $78,125,802 | 43.39% |
| venBio Partners LLC | 4,264,672 | $89,003,705 | 25.24% |
| Bain Capital Life Sciences Investors, LLC | 4,784,674 | $99,856,146 | 11.17% |
| 5AM Venture Management, LLC | 587,600 | $12,263,212 | 3.53% |
| VR Adviser, LLC | 1,563,513 | $32,630,516 | 3.44% |
| Novo Holdings A/S | 1,329,325 | $27,743,013 | 2.05% |
| Cormorant Asset Management, LP | 1,361,460 | $28,413,670 | 1.66% |
| GENERAL ATLANTIC, L.P. | 4,406,252 | $91,958,479 | 1.42% |
| Foresite Capital Management V, LLC | 33,142 | $691,674 | 1.10% |
| Soleus Capital Management, L.P. | 343,975 | $7,178,758 | 0.66% |